![]() Section of GIM Department of Medicine |
William L. Galanter
MD/PhD |
![]()
Position
Assistant Professor of Clinical Medicine
Clinical
Assistant Professor of Pharmacy Practice
Chair, Pharmacy & Therapeutics Committee
Medical Director, UIC Physicians Group
Medical Director, Clinical Information Systems
Chair, Clinical Decision
Support Committee
![]()
Education & Training
B.S., Physics, with honors, University of Illinois, Urbana, 1984
M.S., Physics, University of Illinois, Urbana, 1986
Ph.D., Physiology & Biophysics, University of Illinois at Chicago, 1993
M.D., University of Illinois at Chicago, 1993
Internal Medicine Residency, University of Illinois at Chicago, 1993-96
NBIM Certified in Internal Medicine 1996
Chief Resident, Internal Medicine Residency, University of Illinois at Chicago, 1996-97
Fellow, Faculty Development, Department of Medical Education, 1999-2000
![]()
Abstracts, Editorials & Publications
Schiff, G, Galanter, W, Duhig, J, Lodolce, A, Koronkowski, M, Lambert, B. Twenty-five Principles of Conservative Prescribing. Arch Intern Med. 2011. In press.
Walton S,
Galanter W,
Rosencranz H,
Meltzer D,
Stafford R, Tiryaki F,
Sarne D
A trial of inpatient
indication based prescribing during computerized order entry with medications
commonly used off-label. Applied Clinical Informatics. 2011. In press.
Yu, S. Galanter WL, Didomenico, RJ,
Borkowsky S, Schiff G, Lambert B.
Consensus
list of priority drug-lab linkages for an inpatient asynchronous alert program:
Results of a
Formulary Leveraged Improved Prescribing: Tool for Guiding Critical Formulary
Decision Making.
The AMCP
Format for Formulary Submissions Ver. 3.0.
J
Manag Care Pharm. 2010 Jan;16(1): Supplement,
Appendix G, 2010
Yang Y, Touchette DR, Tiryaki F, Galanter
W et al. Economic analysis of alvimopan
for prevention and management of post-operative Ileus.
Value Health. 2010. Volume: 13 Issue: 3 Pages: A72-A72
Walton S, Galanter W, Tiryaki F, et al. Computerized interventions to obtain interventions to obtain indication information for inpatient prescriptions: A pilot study in drugs frequently used off-label. Value Health. 2010 Volume: 13 Issue: 3 Pages: A87-A87
Patel V, Touchette D, Yang Y, Galanter W
et al. Cost-Effectiveness of strategies
for diagnosing heparin-induced thrombocytopenia.
Value Health. 2010. Volume: 13 Issue: 3 Pages: A209-A209
Nutescu EA, Bautista A, Gao W, Galanter W, Schumock G, Bookhart B, Moody S, Lambert B. Warfarin Anticoagulation After Total Hip or Knee Replacement in Real-World Clinical Practice: INR Patterns and Clinical Outcomes. Chest 2010;138:397A.
Nutescu EA, Bautista A, Gao W, Galanter
W, et al.
Quality of Oral Anticoagulation Management in Pharmacist Versus Nurse Managed
Models of Care.
J
Thromb Thrombolysis. 2010. 29:2 p244-244
Darabi,
H., Galanter, W.L., Lin, J, Buy, U and Sampath, R.
Modeling and Integration
of Hospital Information Systems with Petri Nets,
Proceedings
of the 2009 IEEE International Conference on
Service Operations, Logistics and Informatics. July 2009, 190-195.
Schiff GD and Galanter WL.
Promoting More Conservative Prescribing.
JAMA. 2009;301(8):865-67.
Jao CS, Hier DB, Galanter WL. Using clinical decision support to maintain medication and problem lists: A pilot study to yield higher patient safety. Proc 2008 IEEE Int'l Conf on Systems, Man and Cybernetics. 2008:739-43.
Schiff GD, Duhig JE, Edison MI, Galanter
W,
et al. Drug
Formulary culture survey: Measuring the temperature of clinicians boiling blood.
J Gen Int Med. 2009. 24 p 63-63. Suppl. 1
Duhig J, Edison M, Galanter W, et al.
Conceptual issues in the development of a measure of formulary culture.
Value Health. 2009. 12:3 A8-A8
Tokumaru SM, Garofalo J, Zadoiskaya D, Galanter W, et al.. Clinical use of the modification of diet in renal disease (MDRD) equation in dosing of antimicrobials. Crit Care Med, 2007. 35:12 A241-A241 Suppl. S
GALANTER, W.L. A case study in rules implementation Maryland HIMSS, 2003 (presentation)
GALANTER, W.L, Keeler J and Townsend, J. Transforming Healthcare with Information Technology at the University of Illinois Health System. American Health Imformation Management Assoc. , San Fransisco, 2002 (presentation)
GALANTER, W.L and Polikaitis, A Designing Effective Automated Clinical Decision Support Solutions in the CPOE Environment Partnership for Patient Safety (p4ps) symposium, Washington DC, 2002
GALANTER, W.L., Ruiz, O.S., Labotka, R.J. and Arruda,
J.A.L. : Binding of nitrate to renal brush border membranes studied with [14]N nuclear
magnetic resonance (NMR). Biochim. Biophys. Acta , 1237: 16-22, 1995.
GALANTER, W.L. and Arruda, J.A.L.: Cellular
Adaptation to Hyponatremia: New Insights into the Mechanism. Kidney 4: 209-210, 1995.
GALANTER, W.L., Hakimian, M., and
Labotka, R.J.: Structural determinants of substrate specificity of the erythrocyte
anion transporter. Am. J. Physiol., 265 (Cell Physiol. 34): C918-926, 1993.
Labotka, R.J., GALANTER, W.L., and Misiewicz, V.M.: NMR
spectroscopic studies of Band 3 function using substrate analogs: Substrate specificity,
transport kinetics, and anion binding. Prog. Cell Res. Vol 2, E. Bamberg and H.
Passow (Eds.), 121-128, 1992.
![]()
Active Funding
Tools for Optimizing Prescribing, Monitoring and
Education (TOP-MED), Center for Education and Research on Therapeutics (CERT),
Funding Source AHRQ HS016973-01
PI:
Bruce Lambert. Co-Investigator: William Galanter, 7/2007-6/2011.
The
PI: Ted Mazzone, Consultant:
7/2009-6/2013
Abbott Labs, Communicating Safe and Appropriate drug use to patients and families. Funding Source: Abbott Labs. PI M. Wolfe. Co-Investigator 1/2010-7/2012
The University of
PI: D. Melzer.
Co-Investigator: William Galanter, 3/2010-7/2011.
Regional Centers.
PI: Abel Kho.
Co-Investigator: William Galanter,
1/15/2010-1/14/2014.